BOSTON, MASSACHUSSETTS — Lexie Hearing today unveiled its latest technology, the Lexie B2 Plus Self-fitting OTC Hearing Aids, Powered by Bose. This advanced product features an enhanced in-app hearing test and a newly designed charging carrying case capable of holding a single, up to 18-hour charge, prolonging battery life for users on the move.
“We’re continually striving to introduce top-tier hearing aids to the market, catering to the 44 million Americans experiencing mild to moderate hearing loss. With the launch of the Lexie B2 Plus, we’re delighted to maintain our commitment to providing exceptional hearing solutions supported by award-winning customer service.”
–Nic Klopper, CEO of Lexie Hearing
The Lexie B2 Plus Hearing Aids Powered by Bose offer an optional in-app hearing test, providing wearers with personalized hearing aid settings based on their unique hearing profile.
This feature enables users to establish an optimal initial setting, which they can save as one of their presets. Wearers can further fine-tune their settings to ensure maximum comfort in various environments. The hearing test utilizes diagnostic technology from Lexie Hearing’s parent company, hearX, a global leader in digital audiological equipment.
Users have the flexibility to take the hearing test during the initial setup or while wearing the hearing aids. They can repeat the test as desired. For those who prefer not to use the hearing test feature, manual adjustments for bass, treble levels, and volume are available, granting individuals full control over their hearing experience.
“Hearing is a deeply personal experience, much like a fingerprint,” Klopper explained. “The in-app hearing test simplifies the process of finding the perfect setting for your ears, empowering you to fully engage in the activities you love.”
Price and Availability
This upgraded product builds upon the success of the Lexie B2 Hearing Aids Powered by Bose, which are available from leading retailers such as Amazon, Costco, Best Buy, Walmart, CVS Health, Walgreens, and LexieHearing.com. Recently, the Lexie B2 Hearing Aids were recognized as the top OTC Hearing Aid in the U.S. by Circana, the nation’s premier Retail Tracking Service1. Following the FDA’s approval of over-the-counter hearing aid sales in October 2022, the Lexie B2 Hearing Aid Powered by Bose emerged as the best-selling device based on U.S. dollar and unit sales figures in its first year.
The new B2 Plus hearing aids are offered at $999 online through the company’s webpage. For further details, visit LexieHearing.com.
1. Circana, Retail Tracking Services, U.S., dollar sales, model LBS00001B2 October 2022 – October 2023 combined
About Lexie Hearing
Lexie Hearing, a division of hearX Group, is driven by its mission to make hearing health more affordable and accessible. As a leader in the U.S. OTC hearing aid market, Lexie was named among the 100 Most Influential Companies by TIME in 2023 for its innovative technology and meaningful impact on hearing health in America. Lexie products are clinically proven to provide similar benefits as audiologist-fitted devices for those with mild to moderate hearing loss for up to a quarter of the cost of prescription devices and are sold in more than 14,000 leading retail stores nationwide and on lexiehearing.com. Delivering best-in-class user-friendly technology, an easy-to-use app and award-winning customer service, Lexie helps wearers get back to better hearing quickly and easily so they can confidently live the life they love.
About hearX Group
hearX Group is an industry leading medtech company with a mission to make healthy hearing accessible to everyone, everywhere. Using smart technology, artificial intelligence and data, hearX has built a suite of smart digital solutions to detect, diagnose and treat hearing loss around the globe, making cost-effective hearing healthcare accessible to those who need it most. In a few short years, hearX’s footprint has grown to reach 191 countries and more than 2.4 million people, globally.
Source: Lexie Hearing
